Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Amazon
AMZN
|
+$529M |
| 2 |
Apple
AAPL
|
+$498M |
| 3 |
Procter & Gamble
PG
|
+$497M |
| 4 |
Elanco Animal Health
ELAN
|
+$467M |
| 5 |
AbbVie
ABBV
|
+$397M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$696M |
| 2 |
Intuit
INTU
|
+$535M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$503M |
| 4 |
Intercontinental Exchange
ICE
|
+$459M |
| 5 |
Boeing
BA
|
+$420M |
Sector Composition
| 1 | Technology | 28.58% |
| 2 | Healthcare | 18.93% |
| 3 | Financials | 10.61% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BEAT
1126
DELISTED
BioTelemetry, Inc.
BEAT
| $802K | ﹤0.01% |
20,828
+1,102
| +6% | +$42.4K |
|
|
MNRL
1127
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $799K | ﹤0.01% |
96,668
+26,741
| +38% | +$221K |
|
1128
ESSA Pharma
EPIX
$11.4M
| $796K | ﹤0.01% |
+198,799
| New | +$796K |
|
1129
Neurogene
NGNE
$278M
| $793K | ﹤0.01% |
3,485
+2,894
| +490% | +$659K |
|
1130
Polaris
PII
$3.35B
| $783K | ﹤0.01% |
16,246
| – | – |
|
1131
Devon Energy
DVN
$21.8B
| $781K | ﹤0.01% |
113,278
-99,389
| -47% | -$685K |
|
1132
FS KKR Capital
FSK
$5.07B
| $778K | ﹤0.01% |
+64,969
| New | +$778K |
|
1133
Sabra Healthcare REIT
SBRA
$4.6B
| $775K | ﹤0.01% |
70,972
+14,073
| +25% | +$154K |
|
|
BLUE
1134
DELISTED
bluebird bio
BLUE
| $760K | ﹤0.01% |
1,277
-978
| -43% | -$582K |
|
1135
CSG Systems International
CSGS
$1.88B
| $758K | ﹤0.01% |
+18,107
| New | +$758K |
|
1136
Innoviva
INVA
$1.29B
| $730K | ﹤0.01% |
62,068
+3,290
| +6% | +$38.7K |
|
1137
Under Armour Class C
UA
$2.09B
| $730K | ﹤0.01% |
90,583
-69,990
| -44% | -$564K |
|
1138
Unum
UNM
$12.6B
| $729K | ﹤0.01% |
48,640
-105,229
| -68% | -$1.58M |
|
|
BPYU
1139
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $728K | ﹤0.01% |
85,704
| – | – |
|
|
MFA
1140
MFA Financial
MFA
$1.06B
| $724K | ﹤0.01% |
116,707
| – | – |
|
1141
Trex
TREX
$6.77B
| $721K | ﹤0.01% |
17,984
-1,087,870
| -98% | -$43.6M |
|
1142
Textron
TXT
$14.7B
| $718K | ﹤0.01% |
26,934
-26,935
| -50% | -$718K |
|
1143
United Therapeutics
UTHR
$18.3B
| $704K | ﹤0.01% |
7,425
-48
| -0.6% | -$4.55K |
|
1144
Highwoods Properties
HIW
$3.45B
| $700K | ﹤0.01% |
+19,751
| New | +$700K |
|
1145
Imperial Oil
IMO
$44.5B
| $700K | ﹤0.01% |
62,771
-1,200
| -2% | -$13.4K |
|
1146
PVH
PVH
$4.07B
| $698K | ﹤0.01% |
18,543
-1,635
| -8% | -$61.5K |
|
1147
Inogen
INGN
$228M
| $697K | ﹤0.01% |
13,499
+734
| +6% | +$37.9K |
|
1148
National Research Corp
NRC
$363M
| $695K | ﹤0.01% |
15,281
+819
| +6% | +$37.2K |
|
1149
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$30.6B
| $694K | ﹤0.01% |
5,619
+1,018
| +22% | +$126K |
|
1150
Calavo Growers
CVGW
$485M
| $693K | ﹤0.01% |
12,013
+4,140
| +53% | +$239K |
|